Syneos Health, the only fully integrated biopharmaceutical solutions organization, reported financial results for the three and twelve months ended December 31, 2020.
s common stock; and other risk factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 as updated by the Company’s other SEC filings, copies of which are available free of charge on the Company’s website at investor.syneoshealth.com...
Syneos Health Inc-A(SYNH)股吧,股民朋友可以在这里畅所欲言,分析讨论股票名的最新动态。东方财富股吧,专业的股票论坛社区。
Syneos Health Inc-A(ussynh)股吧,股民朋友可以在这里畅所欲言,分析讨论股票名的最新动态。东方财富股吧,专业的股票论坛社区。
Syneos Health, Inc., the only fully integrated biopharmaceutical solutions organization combining a CRO and a CCO, announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporatio
Syneos Health CEO Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Our CEO Alistair Macdonald was named to the PharmaVOICE 100 - an annual list of the 100 most inspiring leaders in the life sciences industry. Media July 31, 2019 Women of The Week Podcast: Kim John...
Here you’ll find our latest thinking on the changing expectations that people have for marketing and health experiences, how leading brands are keeping up, and the important political and regulatory shifts that impact the context and content of healthcare communications....